| Year |
Citation |
Score |
| 2021 |
Hansel DE. A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers. Urologic Oncology. PMID 34215506 DOI: 10.1016/j.urolonc.2021.05.016 |
0.335 |
|
| 2020 |
Aron M, Park S, Lowenthal BM, Gupta S, Sahoo D, Cheville JC, Hansel DE. Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas. The American Journal of Surgical Pathology. PMID 32868524 DOI: 10.1097/Pas.0000000000001569 |
0.365 |
|
| 2020 |
Epstein JI, Amin MB, Fine SW, Algaba F, Aron M, Baydar DE, Beltran AL, Brimo F, Cheville JC, Colecchia M, Comperat E, da Cunha IW, Delprado W, DeMarzo AM, Giannico GA, ... ... Hansel DE, et al. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. Archives of Pathology & Laboratory Medicine. PMID 32589068 DOI: 10.5858/Arpa.2020-0015-Ra |
0.335 |
|
| 2020 |
Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van Der Kwast T, Xylinas E, ... ... Hansel DE, et al. Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]. European Urology. PMID 32446863 DOI: 10.1016/J.Eururo.2020.03.017 |
0.316 |
|
| 2020 |
Parsons JK, Zahrieh D, Mohler JL, Paskett E, Hansel DE, Kibel AS, Liu H, Seisler DK, Natarajan L, White M, Hahn O, Taylor J, Hartman SJ, Stroup SP, Van Veldhuizen P, et al. Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial. Jama. 323: 140-148. PMID 31935026 DOI: 10.1001/Jama.2019.20207 |
0.339 |
|
| 2019 |
Lowenthal BM, Sahoo D, Amin MB, Hansel DE. Urothelial Proliferation of Unknown Malignant Potential Involving the Bladder: Histopathologic Features and Risk of Progression in De Novo Cases and Cases With Prior Neoplasia. Archives of Pathology & Laboratory Medicine. PMID 31825667 DOI: 10.5858/Arpa.2019-0005-Oa |
0.34 |
|
| 2019 |
Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, ... ... Hansel DE, et al. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees. European Urology. PMID 31753752 DOI: 10.1016/J.Eururo.2019.09.035 |
0.326 |
|
| 2019 |
Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TM, Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TV, Xylinas E, ... ... Hansel DE, et al. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 31740927 DOI: 10.1093/Annonc/Mdz296 |
0.325 |
|
| 2019 |
Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF, Hansel DE. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells. The American Journal of Pathology. PMID 31199921 DOI: 10.1016/J.Ajpath.2019.05.010 |
0.348 |
|
| 2019 |
Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, et al. A comparison of adult rhabdomyosarcoma and high grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. Human Pathology. PMID 30946934 DOI: 10.1016/J.Humpath.2019.03.007 |
0.415 |
|
| 2019 |
Compérat E, Varinot J, Eymerit C, Paner GP, Hansel DE, Amin MB, Moroch J. [Comparison of UICC and AJCC 8th edition TNM classifications in uropathology]. Annales De Pathologie. PMID 30711335 DOI: 10.1016/J.Annpat.2018.12.005 |
0.339 |
|
| 2019 |
Park S, Reuter VE, Hansel DE. Non-urothelial carcinomas of the bladder. Histopathology. 74: 97-111. PMID 30565306 DOI: 10.1111/His.13719 |
0.397 |
|
| 2019 |
Patel SP, Othus M, Chae YK, Giles F, Hansel D, Singh P, Fontaine A, Shah M, Kasi A, Baghdadi TA, Matrana M, Gatalica Z, Korn WM, Hayward J, MMcLeod C, et al. Abstract CT039: A Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) S1609: The neuroendocrine cohort Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct039 |
0.328 |
|
| 2018 |
Compérat E, Babjuk M, Algaba F, Amin M, Brimo F, Grignon D, Hansel D, Hes O, Malavaud B, Reuter V, van der Kwast T. SIU-ICUD on bladder cancer: pathology. World Journal of Urology. 37: 41-50. PMID 30218308 DOI: 10.1007/S00345-018-2466-5 |
0.385 |
|
| 2018 |
Sanchez M, Xia Z, Rico-Bautista E, Cao X, Cuddy M, Castro DJ, Correa RG, Chen L, Yu J, Bobkov A, Ruvolo V, Andreeff M, Oshima RG, Matsuzawa SI, Reed JC, ... ... Hansel D, et al. Oxidized analogs of Di(1-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity. Oncotarget. 9: 25057-25074. PMID 29861853 DOI: 10.18632/Oncotarget.25285 |
0.303 |
|
| 2018 |
Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocrine Pathology. PMID 29453600 DOI: 10.1007/S12022-018-9516-9 |
0.384 |
|
| 2018 |
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. European Urology. PMID 29325693 DOI: 10.1016/J.Eururo.2017.12.018 |
0.377 |
|
| 2018 |
Sahu D, Hansel DE, Klemke R, Boss G. Role of mTORC2 and nitric oxide in bladder cancer invasion. Journal of Clinical Oncology. 36: 504-504. DOI: 10.1200/Jco.2018.36.6_Suppl.504 |
0.433 |
|
| 2018 |
Korkut A, Zaidi S, Kanchi R, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Schultz A, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, ... ... Hansel D, et al. Abstract 3413: A pan-cancer atlas of genomic, epigenomic and transcriptomic alterations in the TGF-β pathway Cancer Research. 78: 3413-3413. DOI: 10.1158/1538-7445.Am2018-3413 |
0.326 |
|
| 2018 |
Gupta S, Cheville J, Hansel D. 218 Modeling E-Cadherin Expression Status to Predict Bladder Cancer Progression American Journal of Clinical Pathology. 149: S93-S93. DOI: 10.1093/Ajcp/Aqx123.217 |
0.328 |
|
| 2017 |
Leivo MZ, Sahoo D, Hamilton Z, Mirsadraei L, Shabaik A, Parsons JK, Kader AK, Derweesh I, Kane C, Hansel DE. Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion. The American Journal of Surgical Pathology. PMID 29076872 DOI: 10.1097/Pas.0000000000000964 |
0.341 |
|
| 2017 |
Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, ... ... Hansel DE, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. PMID 28988769 DOI: 10.1016/J.Cell.2017.09.007 |
0.342 |
|
| 2017 |
Mirsadraei L, Hodkoff A, Jones K, Shabaik A, Kader AK, Saenz CC, Montironi R, Tacha DE, Fadare O, Hansel DE. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall. Archives of Pathology & Laboratory Medicine. PMID 28795841 DOI: 10.5858/Arpa.2017-0004-Oa |
0.366 |
|
| 2017 |
Sahu D, Lotan Y, Wittmann B, Neri B, Hansel DE. Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer. Cancer Medicine. PMID 28766915 DOI: 10.1002/Cam4.1109 |
0.388 |
|
| 2017 |
Duex JE, Owens C, Chauca-Diaz A, Dancik GM, Vanderlinden LA, Ghosh D, Leivo MZ, Hansel DE, Theodorescu D. Nuclear CD24 drives tumor growth and is predictive of poor patient prognosis. Cancer Research. PMID 28674079 DOI: 10.1158/0008-5472.Can-17-0367 |
0.332 |
|
| 2017 |
Hau AM, Nakasaki M, Nakashima K, Krish G, Hansel DE. Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition. Urologic Oncology. PMID 28427860 DOI: 10.1016/J.Urolonc.2017.03.025 |
0.373 |
|
| 2017 |
Hansel DE. The Gleason Grading System: The Approach that Changed Prostate Cancer Assessment. The Journal of Urology. 197: S140-S141. PMID 28010973 DOI: 10.1016/J.Juro.2016.11.028 |
0.319 |
|
| 2017 |
Golconda U, Sokol L, Shokrani B, Lee E, Hansel D, Fadare O, Patel S, Nouraie M, Soleimani H, Sharif Z, Afsari A, Daremipouran F, Brim H, Ashktorab H. Abstract 4578: Does poor prognosis in African Americans with MSI-H colorectal cancer associate with altered immune markers Cancer Research. 77: 4578-4578. DOI: 10.1158/1538-7445.Am2017-4578 |
0.335 |
|
| 2017 |
Hodge KA, Hau A, Pierobon M, Hansel D, Petricoin E. Abstract 222: Protein network mapping of bladder cancer: tumor compartment and microenvironment analysis Cancer Research. 77: 222-222. DOI: 10.1158/1538-7445.Am2017-222 |
0.311 |
|
| 2017 |
Robins DJ, Small AC, Amin MB, Bochner BH, Chang SS, Choueiri TK, Efstathiou JA, Gospodarowicz M, Hansel DE, Kenney PA, Konety BR, Landman J, Lee CT, Leibovich BC, Plimack ER, et al. MP86-17 THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRA Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2700 |
0.341 |
|
| 2016 |
Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, Hansel DE. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. The American Journal of Pathology. PMID 27979310 DOI: 10.1016/J.Ajpath.2016.09.004 |
0.413 |
|
| 2016 |
Hau AM, Leivo MZ, Gilder AS, Hu JJ, Gonias SL, Hansel DE. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. Cellular Signalling. PMID 27777073 DOI: 10.1016/J.Cellsig.2016.10.010 |
0.418 |
|
| 2016 |
Solomon JP, Lowenthal BM, Kader AK, Parsons JK, Flaig TW, Siefker-Radtke AO, Dyrskjøt L, Hansel DE. Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review? Urology. PMID 27769917 DOI: 10.1016/J.Urology.2016.10.014 |
0.349 |
|
| 2016 |
Leivo MZ, Elson PJ, Tacha DE, Delahunt B, Hansel DE. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma. Pathology. 48: 543-9. PMID 27594510 DOI: 10.1016/J.Pathol.2016.05.008 |
0.379 |
|
| 2016 |
Ahmed M, Sottnik JL, Dancik GM, Sahu D, Hansel DE, Theodorescu D, Schwartz MA. An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression. Cancer Cell. PMID 27593345 DOI: 10.1016/J.Ccell.2016.08.002 |
0.352 |
|
| 2016 |
Solomon JP, Hansel DE. The Emerging Molecular Landscape of Urothelial Carcinoma. Surgical Pathology Clinics. 9: 391-404. PMID 27523968 DOI: 10.1016/J.Path.2016.04.004 |
0.38 |
|
| 2016 |
Hansel DE, Reuter VE. Adrenal Pathology in the Adult: A Urological Pathologist's Perspective. Advances in Anatomic Pathology. 23: 273-84. PMID 27438375 DOI: 10.1097/Pap.0000000000000120 |
0.318 |
|
| 2016 |
Sanfrancesco J, McKenney JK, Leivo MZ, Gupta S, Elson P, Hansel DE. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition. Archives of Pathology & Laboratory Medicine. PMID 27031776 DOI: 10.5858/Arpa.2015-0085-Oa |
0.387 |
|
| 2016 |
Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. The American Journal of Pathology. PMID 26988652 DOI: 10.1016/J.Ajpath.2016.01.008 |
0.367 |
|
| 2016 |
Hau AM, Gilder A, Hu J, Gonias SL, Hansel DE. uPAR and mTORC2 as coupled targets for therapeutics development in bladder cancer. Journal of Clinical Oncology. 34: 447-447. DOI: 10.1200/Jco.2016.34.2_Suppl.447 |
0.412 |
|
| 2016 |
Lerner SP, Kim J, Kwiatkowski DJ, Getz G, Weinstein JN, Cherniack A, Guo G, Akbani R, Hoadley KA, Kim WY, Robertson G, Mungall AJ, Hinoue T, Laird PW, Al-Ahmadie H, ... ... Hansel DE, et al. Comprehensive characterization of 412 muscle invasive urothelial carcinomas: Final analysis of The Cancer Genome Atlas (TCGA) project. Journal of Clinical Oncology. 34: 405-405. DOI: 10.1200/Jco.2016.34.2_Suppl.405 |
0.328 |
|
| 2016 |
Sahu D, Lotan Y, Wittman B, Neri B, Hansel DE. Metabolomics analysis of non-muscle invasive and muscle-invasive bladder cancer. Journal of Clinical Oncology. 34: 362-362. DOI: 10.1200/Jco.2016.34.2_Suppl.362 |
0.377 |
|
| 2016 |
Weinstein JN, Lerner SP, Kwiatkowski DJ, Getz G, Kim J, Al-ahmadie HA, Cherniack AD, Guo G, Akbani R, Hoadley KA, Kim WY, Robertson G, Mungall AJ, Hinoue T, Laird PW, ... ... Hansel DE, et al. Abstract 128: Comprehensive molecular characterization of 412 muscle-invasive urothelial bladder carcinomas: final analysis of The Cancer Genome Atlas (TCGA) project Cancer Research. 76: 128-128. DOI: 10.1158/1538-7445.Am2016-128 |
0.397 |
|
| 2016 |
Hau A, Gilder A, Hu J, Gonias S, Hansel D. MP83-19 UPAR AND MTORC2: COUPLED TARGETS FOR THERAPEUTICS DEVELOPMENT IN BLADDER CANCER Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2201 |
0.327 |
|
| 2015 |
Kartha GK, Sanfrancesco J, Udoji E, Chaparala H, Hansel D, Jones JS. Long-term Survival From Muscleinvasive Bladder Cancer With Initial Presentation of Symptomatic Cerebellar Lesion: The Role of Selective Surgical Extirpation of the Primary and Metastatic Lesion. Reviews in Urology. 17: 106-9. PMID 27222649 DOI: 10.3909/Riu0643 |
0.329 |
|
| 2015 |
Solomon JP, Hansel DE. Morphologic and Molecular Characteristics of Bladder Cancer. Surgical Pathology Clinics. 8: 663-76. PMID 26612220 DOI: 10.1016/J.Path.2015.07.003 |
0.439 |
|
| 2015 |
Ikeda S, Hansel DE, Kurzrock R. Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma. Cancer Treatment Reviews. 41: 699-706. PMID 26138514 DOI: 10.1016/J.Ctrv.2015.06.004 |
0.366 |
|
| 2015 |
Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel DE, Jamieson C, Kane CJ, Klatte T, Birner P, Kenner L, et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 521: 94-8. PMID 25924065 DOI: 10.1038/Nature14395 |
0.347 |
|
| 2015 |
Solomon JP, Hansel DE. Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates. Advances in Anatomic Pathology. 22: 102-12. PMID 25664945 DOI: 10.1097/Pap.0000000000000050 |
0.405 |
|
| 2015 |
Kerr BA, Miocinovic R, Smith AK, West XZ, Watts KE, Alzayed AW, Klink JC, Mir MC, Sturey T, Hansel DE, Heston WD, Stephenson AJ, Klein EA, Byzova TV. CD117⁺ cells in the circulation are predictive of advanced prostate cancer. Oncotarget. 6: 1889-97. PMID 25595903 DOI: 10.18632/Oncotarget.2796 |
0.365 |
|
| 2015 |
Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, Lin O, McKenney JK, Montironi R, Paner GP, Al-Ahmadie HA, Algaba F, Ali S, Alvarado-Cabrero I, Bubendorf L, et al. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 612-30. PMID 25412849 DOI: 10.1038/Modpathol.2014.158 |
0.37 |
|
| 2015 |
Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, ... Hansel D, et al. Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward. Urologic Oncology. 33: 53-64. PMID 25065704 DOI: 10.1016/J.Urolonc.2014.06.013 |
0.324 |
|
| 2015 |
Sahu D, Gupta S, Hau AM, Elson P, Bomalaski J, Boss GR, Hansel DE. Abstract 4712: Targeting the arginine-nitric oxide pathway to arrest development and progression of invasive bladder cancer Cancer Research. 75: 4712-4712. DOI: 10.1158/1538-7445.Am2015-4712 |
0.41 |
|
| 2015 |
Das R, Sehgal K, Zhang L, Verma R, Deng Y, Kocoglu M, Vasquez J, Koduru S, Ren Y, Wang M, Couto S, Breider M, Hansel D, Seropian S, Cooper D, et al. Abstract 1354: Comparison of pomalidomide dosing strategies in lenalidomide-refractory myeloma: Impact on clinical outcome, immune activation and cereblon targets Cancer Research. 75: 1354-1354. DOI: 10.1158/1538-7445.Am2015-1354 |
0.313 |
|
| 2014 |
Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urologic Oncology. 32: 1108-15. PMID 25443274 DOI: 10.1016/J.Urolonc.2013.10.021 |
0.338 |
|
| 2014 |
Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TM, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM. Micropapillary bladder cancer: current treatment patterns and review of the literature. Urologic Oncology. 32: 826-32. PMID 24931270 DOI: 10.1016/J.Urolonc.2014.01.020 |
0.363 |
|
| 2014 |
Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Aron M, Luthringer DJ, De Peralta-Venturina M, Cho Y, Amin MB. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Human Pathology. 45: 1473-82. PMID 24780825 DOI: 10.1016/J.Humpath.2014.02.024 |
0.349 |
|
| 2014 |
Guin S, Pollard C, Ru Y, Ritterson Lew C, Duex JE, Dancik G, Owens C, Spencer A, Knight S, Holemon H, Gupta S, Hansel D, Hellerstein M, Lorkiewicz P, Lane AN, et al. Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease. Journal of the National Cancer Institute. 106. PMID 24700805 DOI: 10.1093/Jnci/Dju062 |
0.351 |
|
| 2014 |
Singh K, Sharma A, Mir MC, Drazba JA, Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA, Almasan A. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Molecular Cancer. 13: 70. PMID 24655592 DOI: 10.1186/1476-4598-13-70 |
0.306 |
|
| 2014 |
Weinstein JN, Akbani R, Broom BM, Wang W, Verhaak RGW, McConkey D, Lerner S, Morgan M, Creighton CJ, Smith C, Cherniack AD, Kim J, Pedamallu CS, Noble MS, Al-Ahmadie HA, ... ... Hansel D, et al. Comprehensive molecular characterization of urothelial bladder carcinoma Nature. 507: 315-322. PMID 24476821 DOI: 10.1038/Nature12965 |
0.378 |
|
| 2014 |
Matin SF, Shariat SF, Milowsky MI, Hansel DE, Kassouf W, Koppie T, Bajorin D, Grollman AP. Highlights from the first symposium on upper tract urothelial carcinoma. Urologic Oncology. 32: 309-16. PMID 24397995 DOI: 10.1016/J.Urolonc.2013.08.029 |
0.334 |
|
| 2014 |
Ananthanarayanan V, Pan Y, Tretiakova M, Amin MB, Cheng L, Epstein JI, Grignon DJ, Hansel DE, Jimenez RE, McKenney JK, Montironi R, Oliva E, Osunkoya AO, Rao P, Reuter VE, et al. Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists. The American Journal of Surgical Pathology. 38: 167-75. PMID 24145655 DOI: 10.1097/Pas.0000000000000096 |
0.336 |
|
| 2014 |
Weinstein JN, Kim J, Creighton CJ, Akbani R, Hoadley KA, Kim WY, Morgan MB, Hinoue T, Rosenberg JE, Bajorin DF, Hansel DE, Al-Ahmadie H, Gordenin D, Stuart JM, Robertson G, et al. Comprehensive molecular profiling of urothelial bladder cancer at the DNA, RNA, and protein levels: A TCGA project. Journal of Clinical Oncology. 32: 4509-4509. DOI: 10.1200/Jco.2014.32.15_Suppl.4509 |
0.347 |
|
| 2014 |
Weinstein JN, Kim J, Creighton CJ, Akbani R, Hoadley KA, Kim WY, Morgan MB, Hinoue T, Cherniack A, Su X, Mungall AJ, Ryan MC, Rosenberg JE, Bajorin DF, Czerniak B, ... Hansel D, et al. Abstract 987: Comprehensive characterization of urothelial bladder cancer: a TCGA Project update Cancer Research. 74: 987-987. DOI: 10.1158/1538-7445.Am2014-987 |
0.37 |
|
| 2013 |
Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. Plos One. 8: e81081. PMID 24312263 DOI: 10.1371/Journal.Pone.0081081 |
0.414 |
|
| 2013 |
Hansel DE, Zhang Z, Petillo D, Teh BT. Gene profiling suggests a common evolution of bladder cancer subtypes. Bmc Medical Genomics. 6: 42. PMID 24134934 DOI: 10.1186/1755-8794-6-42 |
0.432 |
|
| 2013 |
Sanfrancesco J, Jones JS, Hansel DE. Diagnostically challenging cases: what are atypia and dysplasia? The Urologic Clinics of North America. 40: 281-93. PMID 23540785 DOI: 10.1016/J.Ucl.2013.01.006 |
0.306 |
|
| 2013 |
Hansel DE, Miller JS, Cookson MS, Chang SS. Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist. Urology. 81: 1123-30. PMID 23522296 DOI: 10.1016/J.Urology.2013.01.027 |
0.376 |
|
| 2013 |
Zhou N, Singh K, Mir MC, Parker Y, Lindner D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A, Hansel DE. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1717-28. PMID 23403633 DOI: 10.1158/1078-0432.Ccr-12-2383 |
0.399 |
|
| 2013 |
Patel AR, Cohn JA, Abd El Latif A, Miocinovic R, Steinberg GD, Paner GP, Hansel DE. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. The Journal of Urology. 189: 53-8. PMID 23164389 DOI: 10.1016/J.Juro.2012.09.006 |
0.379 |
|
| 2013 |
Hansel DE, Amin MB, Comperat E, Cote RJ, Knüchel R, Montironi R, Reuter VE, Soloway MS, Umar SA, Van der Kwast TH. A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. European Urology. 63: 321-32. PMID 23088996 DOI: 10.1016/J.Eururo.2012.10.008 |
0.39 |
|
| 2013 |
Abd El-Latif A, Watts KE, Elson P, Fergany A, Hansel DE. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. The Journal of Urology. 189: 1263-7. PMID 23085297 DOI: 10.1016/J.Juro.2012.10.054 |
0.393 |
|
| 2013 |
Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. European Urology. 63: 16-35. PMID 23083804 DOI: 10.1016/J.Eururo.2012.09.063 |
0.371 |
|
| 2013 |
Gulmann C, Paner GP, Parakh RS, Hansel DE, Shen SS, Ro JY, Annaiah C, Lopez-Beltran A, Rao P, Arora K, Cho Y, Herrera-Hernandez L, Alsabeh R, Amin MB. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Human Pathology. 44: 164-72. PMID 22995333 DOI: 10.1016/J.Humpath.2012.05.018 |
0.373 |
|
| 2013 |
Svatek RS, Rosenberg JE, Galsky MD, Lee CT, Latini DM, Bochner BH, Weizer AZ, Apolo AB, Sridhar SS, Kamat AM, Hansel D, Flaig TW, Smith ND, Lotan Y. Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic research. Urologic Oncology. 31: 968-73. PMID 22300756 DOI: 10.1016/J.Urolonc.2011.12.017 |
0.347 |
|
| 2013 |
Gupta S, Maria M, Bomalaski J, Elson PJ, Singh K, Harwalkar J, Carver P, Almasan A, Hansel DE. Abstract 11: Arginine deprivation therapy using ADI-PEG20 as a novel therapeutic modality in the treatment of bladder cancer. Cancer Research. 73: 11-11. DOI: 10.1158/1538-7445.Am2013-11 |
0.437 |
|
| 2013 |
Wang L, Shabaik A, Hansel DE. Squamous lesions of the bladder Diagnostic Histopathology. 19: 376-380. DOI: 10.1016/J.Mpdhp.2013.08.007 |
0.352 |
|
| 2012 |
Chang SS, Dinney CP, Donat SM, Dahm P, Gore JL, Lotan Y, Parekh DJ, Solit DB, O'Donnell PH, Feng FY, Hansel D, Milowsky MI. 12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report. Urologic Oncology. 30: 944-7. PMID 23218073 DOI: 10.1016/J.Urolonc.2012.07.006 |
0.363 |
|
| 2012 |
Gruver AM, Amin MB, Luthringer DJ, Westfall D, Arora K, Farver CF, Osunkoya AO, McKenney JK, Hansel DE. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Archives of Pathology & Laboratory Medicine. 136: 1339-46. PMID 23106579 DOI: 10.5858/Arpa.2011-0575-Oa |
0.352 |
|
| 2012 |
Fahed E, Hansel DE, Raghavan D, Quinn DI, Dorff TB. Small cell bladder cancer: biology and management. Seminars in Oncology. 39: 615-8. PMID 23040258 DOI: 10.1053/J.Seminoncol.2012.08.009 |
0.394 |
|
| 2012 |
Mitra AP, Hansel DE, Cote RJ. Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Seminars in Oncology. 39: 524-33. PMID 23040249 DOI: 10.1053/J.Seminoncol.2012.08.008 |
0.413 |
|
| 2012 |
Gupta R, Billis A, Shah RB, Moch H, Osunkoya AO, Jochum W, Hes O, Bacchi CE, de Castro MG, Hansel DE, Zhou M, Vankalakunti M, Salles PG, Cabrera RA, Gown AM, et al. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. The American Journal of Surgical Pathology. 36: 1265-78. PMID 22895263 DOI: 10.1097/Pas.0B013E3182635954 |
0.348 |
|
| 2012 |
Watts KE, Montironi R, Mazzucchelli R, van der Kwast T, Osunkoya AO, Stephenson AJ, Hansel DE. Clinicopathologic characteristics of 23 cases of invasive low-grade papillary urothelial carcinoma. Urology. 80: 361-6. PMID 22857755 DOI: 10.1016/J.Urology.2012.04.010 |
0.36 |
|
| 2012 |
Chan ES, Patel AR, Hansel DE, Larchian WA, Heston WD. Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model. Urology. 80: 736.e1-5. PMID 22676953 DOI: 10.1016/J.Urology.2012.04.038 |
0.35 |
|
| 2012 |
Paner GP, Aron M, Hansel DE, Amin MB. Non-epithelial neoplasms of the prostate. Histopathology. 60: 166-86. PMID 22212085 DOI: 10.1111/J.1365-2559.2011.04020.X |
0.352 |
|
| 2012 |
Gupta S, Bomalaski JS, Carver PD, Hansel DE. Abstract 3652: Pegylated arginine deiminase (ADI-PEG20) as a potential therapeutic agent for rarer variants of bladder cancer that are deficient for argininosuccinate synthetase Cancer Research. 72: 3652-3652. DOI: 10.1158/1538-7445.Am2012-3652 |
0.451 |
|
| 2012 |
Diaz E, Yang JJ, Hansel D. 881 DEVELOPMENT OF PRIMARY UROTHELIAL CARCINOMA TUMOR SPHERES IN SERUM FREE IN VITRO CONDITIONS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.976 |
0.327 |
|
| 2012 |
Abd El Latif A, Miocinovic R, Salem H, Massoud A, Stephenson AJ, Hansel D. 1412 VALIDATION OF NEW STAGING SYSTEM FOR PATIENTS WITH INVASIVE UROTHELIAL CARCINOMA OF THE PROSTATE Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1863 |
0.342 |
|
| 2011 |
Harshman LC, Manda S, Hansel DE, McKenney J, Oliveira V, Simon N, Dreicer R, Srinivas S, Bepler G. ERCC1 and RRM1 expression patterns in synchronous primary and metastatic urothelial cancer lesions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15035. PMID 28020389 DOI: 10.1200/Jco.2011.29.15_Suppl.E15035 |
0.369 |
|
| 2011 |
Miocinovic R, Gong MC, Ghoneim IA, Fergany AF, Hansel DE, Stephenson AJ. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study. The Journal of Urology. 186: 1269-73. PMID 21849181 DOI: 10.1016/J.Juro.2011.05.088 |
0.302 |
|
| 2011 |
Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 1521-9. PMID 21725290 DOI: 10.1038/Modpathol.2011.112 |
0.435 |
|
| 2011 |
Hansel DE, Paner GP, Nese N, Amin MB. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. Human Pathology. 42: 1770-6. PMID 21683983 DOI: 10.1016/J.Humpath.2011.02.022 |
0.34 |
|
| 2011 |
Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC, Jones JS, Campbell SC, Hansel DE. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 78: 82-6. PMID 21550642 DOI: 10.1016/J.Urology.2011.02.038 |
0.344 |
|
| 2011 |
Ching CB, Amin MB, Tubbs RR, Elson P, Platt E, Dreicer R, Fergany A, Hansel DE. HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 1111-9. PMID 21516078 DOI: 10.1038/Modpathol.2011.69 |
0.339 |
|
| 2011 |
Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D. CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Research. 71: 3802-11. PMID 21482678 DOI: 10.1158/0008-5472.Can-11-0519 |
0.348 |
|
| 2011 |
Ghoneim IA, Miocinovic R, Stephenson AJ, Garcia JA, Gong MC, Campbell SC, Hansel DE, Fergany AF. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology. 77: 867-70. PMID 21296399 DOI: 10.1016/J.Urology.2010.11.043 |
0.346 |
|
| 2011 |
Zhou N, Singh K, Almasan A, Hansel D. Abstract 3599: Aurora kinase inhibitors as a novel targeted drug therapy for bladder cancer Cancer Research. 71: 3599-3599. DOI: 10.1158/1538-7445.Am2011-3599 |
0.387 |
|
| 2011 |
Hansel DE. Biopsy Interpretation of the Bladder, Second Edition The American Journal of Surgical Pathology. 35: 1603. DOI: 10.1097/Pas.0B013E318225492E |
0.314 |
|
| 2011 |
Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE. Erratum: Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature Modern Pathology. 24: 1531-1531. DOI: 10.1038/Modpathol.2011.131 |
0.359 |
|
| 2011 |
Abd El-Latif A, Fergany A, Hansel DE. 1247 THE SENSITIVITY OF INITIAL TURB ON DETECTING BLADDER CANCER VARIANTS ON RADICAL CYSTECTOMY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.918 |
0.414 |
|
| 2011 |
Diaz E, Ching C, Elson P, Hansel D. 1402 CANCER STEM CELL MARKER EXPRESSION IN MUSCLE-INVASIVE UROTHELIAL CARCINOMA Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1293 |
0.383 |
|
| 2011 |
Diaz E, Ching C, Hansel D. 1070 DEVELOPMENT OF A RAPAMYCIN SENSITIVE CELL LINE FROM UROTHELIAL CARCINOMA WITH SARCOMATOID FEATURES Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1107 |
0.314 |
|
| 2010 |
Zhang Z, Furge KA, Yang XJ, Teh BT, Hansel DE. Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. Bmc Medical Genomics. 3: 58. PMID 21159190 DOI: 10.1186/1755-8794-3-58 |
0.354 |
|
| 2010 |
Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. The American Journal of Surgical Pathology. 34: 1367-76. PMID 20717002 DOI: 10.1097/Pas.0B013E3181Ec86B3 |
0.381 |
|
| 2010 |
Kim JJ, Rini BI, Hansel DE. Von Hippel Lindau syndrome. Advances in Experimental Medicine and Biology. 685: 228-49. PMID 20687511 DOI: 10.1007/978-1-4419-6448-9_22 |
0.303 |
|
| 2010 |
Ching CB, Hansel DE. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 1406-14. PMID 20661228 DOI: 10.1038/Labinvest.2010.133 |
0.339 |
|
| 2010 |
Allende DS, Desai M, Hansel DE. Primary lymphoepithelioma-like carcinoma of the ureter. Annals of Diagnostic Pathology. 14: 209-14. PMID 20471568 DOI: 10.1016/J.Anndiagpath.2009.05.007 |
0.396 |
|
| 2010 |
Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Hansel DE, Amin MB. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. The American Journal of Surgical Pathology. 34: 792-9. PMID 20421781 DOI: 10.1097/Pas.0B013E3181Da7650 |
0.406 |
|
| 2010 |
Watts KE, Hansel DE. Emerging concepts in micropapillary urothelial carcinoma. Advances in Anatomic Pathology. 17: 182-6. PMID 20418672 DOI: 10.1097/Pap.0B013E3181D97851 |
0.37 |
|
| 2010 |
Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma. The American Journal of Pathology. 176: 3062-72. PMID 20395440 DOI: 10.2353/Ajpath.2010.090872 |
0.32 |
|
| 2010 |
Wang WP, Guo C, Berney DM, Ulbright TM, Ubright TM, Hansel DE, Shen R, Ali T, Epstein JI. Primary carcinoid tumors of the testis: a clinicopathologic study of 29 cases. The American Journal of Surgical Pathology. 34: 519-24. PMID 20351489 DOI: 10.1097/Pas.0B013E3181D31F33 |
0.347 |
|
| 2010 |
Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology. 75: 382-6. PMID 19819539 DOI: 10.1016/J.Urology.2009.07.1259 |
0.335 |
|
| 2010 |
Verheul HM, van Erp K, Homs MY, Yoon GS, van der Groep P, Rogers C, Hansel DE, Netto GJ, Pili R. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology. 75: 608-14. PMID 19683801 DOI: 10.1016/J.Urology.2009.05.075 |
0.34 |
|
| 2010 |
Orloff M, Elson P, Yang Y, Eng C, Hansel DE. Abstract 1810: PTEN association with mTOR pathway activation and outcomes in bladder cancer Cancer Research. 70: 1810-1810. DOI: 10.1158/1538-7445.Am10-1810 |
0.384 |
|
| 2010 |
Irwin B, Berger A, Brandina R, Stein R, Shah S, Hansel D, Desai M. 423 RISK OF TRACT RECURRENCE FOLLOWING PERCUTANEOUS RESECTION FOR UPPER TRACT UROTHELIAL CARCINOMA: CLINICAL, PATHOLOGIC AND RADIOLOGIC EVALUATION Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.493 |
0.325 |
|
| 2009 |
Coleman JF, Hansel DE. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder. Advances in Anatomic Pathology. 16: 67-78. PMID 19550368 DOI: 10.1097/Pap.0B013E318199F89E |
0.38 |
|
| 2009 |
He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, Parmigiani G, Matsui W, Berman DM. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells (Dayton, Ohio). 27: 1487-95. PMID 19544456 DOI: 10.1002/Stem.92 |
0.411 |
|
| 2009 |
Weight CJ, Garcia JA, Hansel DE, Fergany AF, Campbell SC, Gong MC, Jones JS, Klein EA, Dreicer R, Stephenson AJ. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series. Cancer. 115: 792-9. PMID 19127557 DOI: 10.1002/Cncr.24106 |
0.366 |
|
| 2009 |
Hansel DE, Nakayama M, Luo J, Abukhdeir AM, Park BH, Bieberich CJ, Hicks JL, Eisenberger M, Nelson WG, Mostwin JL, De Marzo AM. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate. The Prostate. 69: 603-9. PMID 19125417 DOI: 10.1002/Pros.20910 |
0.353 |
|
| 2009 |
Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Human Pathology. 40: 108-16. PMID 18789486 DOI: 10.1016/J.Humpath.2008.06.022 |
0.37 |
|
| 2009 |
Smith AK, Lane BR, Larson BT, Berger A, Hansel DE, Gong MC, Campbell SC, Gill IS, Stephenson AJ. DOES THE CHOICE OF TECHNIQUE FOR MANAGEMENT OF THE BLADDER CUFF AFFECT ONCOLOGIC OUTCOMES OF NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CANCER? Journal of Urology. 181: 133-134. DOI: 10.1016/S0022-5347(09)60385-2 |
0.318 |
|
| 2009 |
Smith AK, Larson BT, Berger A, Lane BR, Hansel DE, Stephenson AJ, Jones JS. IS THERE A ROLE FOR CYTOLOGY IN THE DIAGNOSIS OF UPPER TRACT UROTHELIAL CANCER? Journal of Urology. 181: 132-132. DOI: 10.1016/S0022-5347(09)60382-7 |
0.371 |
|
| 2008 |
Coleman JF, Hansel DE. Benign Diseases of the Bladder. Surgical Pathology Clinics. 1: 129-58. PMID 26837905 DOI: 10.1016/J.Path.2008.07.001 |
0.311 |
|
| 2008 |
Hansel DE, Netto GJ, Montgomery EA, Epstein JI. Mesenchymal Tumors of the Prostate. Surgical Pathology Clinics. 1: 105-28. PMID 26837904 DOI: 10.1016/J.Path.2008.07.003 |
0.328 |
|
| 2008 |
Lane Z, Hansel DE, Epstein JI. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. The American Journal of Surgical Pathology. 32: 1322-6. PMID 18670358 DOI: 10.1097/Pas.0B013E3181656Ca0 |
0.373 |
|
| 2008 |
Hansel DE, Swain E, Dreicer R, Tubbs RR. HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases. American Journal of Clinical Pathology. 130: 274-81. PMID 18628098 DOI: 10.1309/41Vltfx3Ypp1Hf6F |
0.357 |
|
| 2008 |
Osunkoya AO, Hansel DE, Parwani AV, Ali TZ, Tamas EF, Untawale VG, Kahane H, Epstein JI. The Symphony protocol for H&E staining of prostatic adenocarcinoma on needle biopsy: a multicentre analysis of 120 cases. Pathology. 40: 450-6. PMID 18604729 DOI: 10.1080/00313020802198127 |
0.326 |
|
| 2008 |
Hansel DE, Rini BI. Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities. Expert Review of Anticancer Therapy. 8: 895-905. PMID 18533799 DOI: 10.1586/14737140.8.6.895 |
0.337 |
|
| 2008 |
Smith AK, Hansel DE, Jones JS. Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma. Urology. 71: 915-8. PMID 18455631 DOI: 10.1016/J.Urology.2007.11.079 |
0.331 |
|
| 2008 |
Osunkoya AO, Hansel DE, Sun X, Netto GJ, Epstein JI. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. The American Journal of Surgical Pathology. 32: 461-7. PMID 18300803 DOI: 10.1097/Pas.0B013E318157020E |
0.398 |
|
| 2008 |
Stephenson AJ, Campbell SC, Fergany A, Gong MC, Klein EA, Hansel DE. COMPREHENSIVE HISTOPATHOLOGIC ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH LYMPH NODE- POSITIVE BLADDER CANCER Journal of Urology. 179: 548-549. DOI: 10.1016/S0022-5347(08)61615-8 |
0.328 |
|
| 2007 |
Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R, Hansel DE. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. The American Journal of Surgical Pathology. 31: 1777-87. PMID 18043032 DOI: 10.1097/Pas.0B013E31805C9Cd9 |
0.361 |
|
| 2007 |
Hansel DE, Epstein JI, Berbescu E, Fine SW, Young RH, Cheville JC. Renal carcinoid tumor: a clinicopathologic study of 21 cases. The American Journal of Surgical Pathology. 31: 1539-44. PMID 17895755 DOI: 10.1097/Pas.0B013E318042D596 |
0.312 |
|
| 2007 |
Hansel DE, Nadasdy T, Epstein JI. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma. The American Journal of Surgical Pathology. 31: 1231-7. PMID 17667548 DOI: 10.1097/Pas.0B013E31802E290D |
0.378 |
|
| 2007 |
Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, Partin AW, Netto GJ. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies. The Journal of Urology. 177: 1736-40. PMID 17437801 DOI: 10.1016/J.Juro.2007.01.013 |
0.335 |
|
| 2007 |
Hansel DE, Herawi M, Montgomery E, Epstein JI. Spindle cell lesions of the adult prostate. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 148-58. PMID 17170745 DOI: 10.1038/Modpathol.3800676 |
0.337 |
|
| 2007 |
Thomas A, Stephenson AJ, Campbell SC, Hansel DE. 1519: Comparison of Outcomes in Squamous Cell Carcinoma of the Bladder Versus Urothelial Carcinoma with Squamous Differentiation Journal of Urology. 177: 501-502. DOI: 10.1016/S0022-5347(18)31720-8 |
0.35 |
|
| 2006 |
Hansel DE, Epstein JI. Sarcomatoid carcinoma of the prostate: a study of 42 cases. The American Journal of Surgical Pathology. 30: 1316-21. PMID 17001164 DOI: 10.1097/01.Pas.0000209838.92842.Bf |
0.355 |
|
| 2006 |
Hansel DE, Meeker AK, Hicks J, De Marzo AM, Lillemoe KD, Schulick R, Hruban RH, Maitra A, Argani P. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 772-9. PMID 16557277 DOI: 10.1038/Modpathol.3800591 |
0.368 |
|
| 2006 |
Hansel DE. Genetic alterations and histopathologic findings in familial renal cell carcinoma. Histology and Histopathology. 21: 437-44. PMID 16437389 DOI: 10.14670/Hh-21.437 |
0.322 |
|
| 2006 |
House MG, Cameron JL, Lillemoe KD, Schulick RD, Choti MA, Hansel DE, Hruban RH, Maitra A, Yeo CJ. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 10: 138-45. PMID 16368504 DOI: 10.1016/J.Gassur.2005.05.004 |
0.323 |
|
| 2005 |
Hansel DE, Maitra A, Lin JW, Goggins M, Argani P, Yeo CJ, Piantadosi S, Leach SD, Biankin AV. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1811-8. PMID 15774774 DOI: 10.1200/Jco.2005.03.068 |
0.305 |
|
| 2005 |
Hansel DE, Ashfaq R, Rahman A, Wanzer D, Yeo CJ, Wilentz RE, Maitra A. A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment. American Journal of Clinical Pathology. 123: 28-35. PMID 15762277 DOI: 10.1309/P3Chdx9Ly6H2Ly0G |
0.31 |
|
| 2005 |
Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E. CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. The American Journal of Surgical Pathology. 29: 390-9. PMID 15725809 DOI: 10.1097/00000478-200503000-00014 |
0.375 |
|
| 2005 |
Hansel DE, Rahman A, Wilentz RE, Shih IeM, McMaster MT, Yeo CJ, Maitra A. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. International Journal of Gastrointestinal Cancer. 35: 15-23. PMID 15722570 DOI: 10.1385/Ijgc:35:1:015 |
0.36 |
|
| 2004 |
Hansel DE, Rahman A, House M, Ashfaq R, Berg K, Yeo CJ, Maitra A. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6152-8. PMID 15448002 DOI: 10.1158/1078-0432.Ccr-04-0285 |
0.325 |
|
| 2004 |
Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. The American Journal of Surgical Pathology. 28: 347-56. PMID 15104297 DOI: 10.1097/00000478-200403000-00007 |
0.413 |
|
| 2004 |
Hansel DE, Maitra A, Argani P. Pathology of the gallbladder: A concise review Current Diagnostic Pathology. 10: 304-317. DOI: 10.1016/J.Cdip.2004.03.006 |
0.392 |
|
| 2003 |
Hansel DE, House MG, Ashfaq R, Rahman A, Yeo CJ, Maitra A. MAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases. International Journal of Gastrointestinal Cancer. 33: 141-7. PMID 14716063 DOI: 10.1385/Ijgc:33:2-3:141 |
0.331 |
|
| 2003 |
Rahman A, Maitra A, Ashfaq R, Yeo CJ, Cameron JL, Hansel DE. Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms. American Journal of Clinical Pathology. 120: 685-90. PMID 14608893 DOI: 10.1309/Lpjbrgqx95Kry3G3 |
0.301 |
|
| 2003 |
Hansel DE, Kern SE, Hruban RH. Molecular pathogenesis of pancreatic cancer. Annual Review of Genomics and Human Genetics. 4: 237-56. PMID 14527303 DOI: 10.1146/Annurev.Genom.4.070802.110341 |
0.354 |
|
| 2003 |
Hansel DE, Rahman A, Hidalgo M, Thuluvath PJ, Lillemoe KD, Shulick R, Ku JL, Park JG, Miyazaki K, Ashfaq R, Wistuba II, Varma R, Hawthorne L, Geradts J, Argani P, et al. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. The American Journal of Pathology. 163: 217-29. PMID 12819026 DOI: 10.1016/S0002-9440(10)63645-0 |
0.401 |
|
| 2001 |
Hansel DE, Eipper BA, Ronnett GV. Regulation of olfactory neurogenesis by amidated neuropeptides. Journal of Neuroscience Research. 66: 1-7. PMID 11598996 DOI: 10.1002/Jnr.1191 |
0.554 |
|
| 2001 |
Hansel DE, May V, Eipper BA, Ronnett GV. Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4625-36. PMID 11425890 |
0.508 |
|
| 2001 |
Hansel DE, Quiñones ME, Ronnett GV, Eipper BA. Kalirin, a GDP/GTP exchange factor of the Dbl family, is localized to nerve, muscle, and endocrine tissue during embryonic rat development. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 49: 833-44. PMID 11410608 DOI: 10.1177/002215540104900704 |
0.559 |
|
| 2001 |
Hansel DE, Eipper BA, Ronnett GV. Neuropeptide Y functions as a neuroproliferative factor. Nature. 410: 940-4. PMID 11309620 DOI: 10.1038/35073601 |
0.554 |
|
| Show low-probability matches. |
